Circulating lymphocytes can secrete several cytokines, such as IFN-γ and TNF-α, to control tumor growth and improve prognosis of cancer patients [32], and the decreased lymphocyte count and function cannot be responsible for immune surveillance to remove tumor cells [25, 32]. This evidence concerns the gene IFNG and cancer.